Akèy › Maladi Crohn › Missouri › Kansas City

Etid klinik pou Maladi Crohn nan Kansas City, MO

5 etid pou Maladi Crohn ap chèche patisipan nan sit nan ak bò kote Kansas City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Ap rekriteFaz 1

University Health Truman Medical Center, Kansas City
University of Kansas Cancer Center - North, Kansas City
University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT03816345

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Ap rekriteFaz 3

Mid-America GI Clinical Research ( Site 5130), Kansas City

Laj 16 a 80 · Tout sèks · Mizajou Oct 2, 2026 · NCT06430801

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Ap rekriteFaz 4

Mid America Gastro Intestinal Consultants, Kansas City

Laj 18 a 80 · Tout sèks · Mizajou Sep 30, 2026 · NCT06581328

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Ap rekriteFaz 4

Mid-America Gastro-Intestinal Consultants, Kansas City

Laj 18 a 70 · Tout sèks · Mizajou Sep 9, 2026 · NCT06045754

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Ap rekriteFaz 2

Mirador Therapeutics Selected Site, Kansas City

Laj 18 a 80 · Tout sèks · Mizajou Mar 12, 2026 · NCT07113522

Etid Maladi Crohn nan lòt vil

Lòt etid nan Kansas City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.